LGALS3 and hydrops fetalis: Grandin EW and colleagues have shown that patients with elevated Gal-3 and BNP levels were at the highest odds of developing HF, suggesting a potential incremental value of Gal-3 for assessment of HF risk after ACS (pilot experience from PROVE IT-TIMI 22) [32].